<code id='FBA6ECDE90'></code><style id='FBA6ECDE90'></style>
    • <acronym id='FBA6ECDE90'></acronym>
      <center id='FBA6ECDE90'><center id='FBA6ECDE90'><tfoot id='FBA6ECDE90'></tfoot></center><abbr id='FBA6ECDE90'><dir id='FBA6ECDE90'><tfoot id='FBA6ECDE90'></tfoot><noframes id='FBA6ECDE90'>

    • <optgroup id='FBA6ECDE90'><strike id='FBA6ECDE90'><sup id='FBA6ECDE90'></sup></strike><code id='FBA6ECDE90'></code></optgroup>
        1. <b id='FBA6ECDE90'><label id='FBA6ECDE90'><select id='FBA6ECDE90'><dt id='FBA6ECDE90'><span id='FBA6ECDE90'></span></dt></select></label></b><u id='FBA6ECDE90'></u>
          <i id='FBA6ECDE90'><strike id='FBA6ECDE90'><tt id='FBA6ECDE90'><pre id='FBA6ECDE90'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:811
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Live blog: Hearing on CRISPR
          Live blog: Hearing on CRISPR

          AdobeTheFoodandDrugAdministrationisconveningameetingofoutsideexpertsonTuesdaytoreviewexa-cel,aCRISPR

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          H.R. 3 is the wrong path to lower drug costs

          Fromleft,Rep.RichardNeal(D-Mass.)speaksasRep.FrankPallone(D-N.J.)andHouseSpeakerNancyPelosi(D-Calif.